Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 05, 2026 08:45 ET | Source: Autonomix Medical, Inc.

Autonomix Medical Selected for Best Innovation Competition at CRT 2026

THE WOODLANDS, TX, March 05, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted...
March 04, 2026 08:40 ET | Source: Autonomix Medical, Inc.

Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis

THE WOODLANDS, TX, March 04, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted...
November 18, 2025 08:30 ET | Source: Autonomix Medical, Inc.

Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq Rules

THE WOODLANDS, TX, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted...
October 08, 2025 12:00 ET | Source: Unyte Health

Unyte Health Celebrates 10 Years as the Leader in Nervous System Regulation and Sound-Based Listening Therapies

Unyte Health marks 10 years as the leader of evidence-based listening therapies that support nervous system regulation, resilience, and mind-body wellness.
February 26, 2025 09:00 ET | Source: Autonomix Medical, Inc.

Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the LSI USA ’25 Emerging Medtech Summit

THE WOODLANDS, TX, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing innovative technologies to...
January 15, 2025 08:30 ET | Source: Autonomix Medical, Inc.

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series

Live video webcast on Wednesday, January 22nd at 4:00 PM ET THE WOODLANDS, TX, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical...
November 20, 2024 09:04 ET | Source: Olo

Olo Launches at Slush 2024: Sound and Somatics for Nervous System Resilience

Olo, a mental wellness platform, unveiled its science-backed audio journeys for stress relief and nervous system resilience at Slush 2024.
October 10, 2024 10:00 ET | Source: Unyte Health

$3.8 Million Department of Defense Grant Awarded for Groundbreaking Study on Safe and Sound Protocol in PTSD Treatment

The study aims to determine if filtered music as an adjunct therapy can reduce PTSD symptoms and enhance treatment for civilian and military populations.
June 10, 2024 08:00 ET | Source: Autonomix Medical, Inc.

Autonomix to Announce Preliminary Topline Results from First Five Lead-In Patients in Ongoing Human Clinical Trial on June 18, 2024

Management to host live webcast to discuss results on Tuesday, June 18th at 8:30 a.m. ET THE WOODLANDS, TX, June 10, 2024 (GLOBE NEWSWIRE) -- – Autonomix Medical, Inc. (NASDAQ: AMIX)...
February 23, 2024 08:50 ET | Source: Autonomix Medical, Inc.

Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Lunch Break: The Autonomix Opportunity

Live webcast with Lori Bisson, Chief Executive Officer of Autonomix, on Thursday, February 29th at 12:00 PM ET THE WOODLANDS, TX, Feb. 23, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ:...